Hypoglycemic and hypotensive activity of a root extract of Smilax aristolochiifolia, standardized on N-trans-feruloyl-tyramine

Molecules

Volumn 19, Issue 8, 2014, Pages 11366-11384

  Amaro, Carol Arely Botello ^a,b   González Cortazar, Manasés ^a   Herrera Ruiz, Maribel ^a   Román Ramos, Rubén ^b   Aguilar Santamaría, Lucia ^a   Tortoriello, Jaime ^a   Jiménez Ferrer, Enrique ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

Author keywords

Metabolic syndrome; N trans feruloyl tyramine; Smilax aristolochiifolia Smilacaceae

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; COUMARIC ACID; FERULOYLTYRAMINE; PLANT EXTRACT; TYRAMINE;

ANALOGS AND DERIVATIVES; ANIMAL; BLOOD PRESSURE; CHEMICAL STRUCTURE; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; METABOLISM; MOUSE; PLANT ROOT; SARSAPARILLA;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COUMARIC ACIDS; DISEASE MODELS, ANIMAL; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MICE; MOLECULAR STRUCTURE; PLANT EXTRACTS; PLANT ROOTS; SMILAX; TYRAMINE;

EID: 84906707605     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190811366     Document Type: Article

References (41)

1. Yun, J.E.; Won, S.; Sung, J.; Jee, S.H. Impact of metabolic syndrome independent of insulin resistance on the development of cardiovascular disease. Circ. J. 2012, 76, 2443-2448.
2. Hutcheson, R.; Rocic, P. The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: The great exploration. Exp. Diabetes Res. 2012, 2012, 271028.
3. Rojas-Martínez, R.; Aguilar-Salinas, C.A.; Jiménez-Corona, A.; Gómez-Pérez, F.J.; Barquera, S.; Lazcano-Ponce, E. Prevalence of obesity and metabolic syndrome components in Mexican adults without type 2 diabetes or hypertension. Salud Pública Mexico 2012, 54, 7-12.
4. Gómez-Dantés, O.; Sesma, S.; Becerril, V.M.; Knaul, F.M.; Arreola, H.; Frenk, J. Sistema de Salud de México (In Spanish). Salud Pública Mexico 2011, 53, S220-S232.
5. Kalupahana, N.S.; Claycombe, K.J.; Moustaid-Moussa, N. (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: Mechanistic insights. Adv. Nutr. 2011, 2, 304-316.
6. Ferdinand, K.C. Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy. Cardiorenal. Med. 2012, 2, 256-267.
7. Fraulob, J.C.; Ogg-Diamantino, R.; Fernandes-Santos, C.; Águila, M.B. A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet. J. Clin. Biochem. Nutr. 2010, 46, 212-223.
8. Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 2006, 444, 860-867.
9. Touyz, R.M. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: Role of angiotensin II. Exp. Physiol. 2005, 90, 449-455.
10. Bo, S.; Hongzhu, G.; Yajun, C.; Min, Y.; Jian, H.; Dean, G. Steroidal saponins from Smilax china and their anti-inflammatory activities. Phytochemistry 2007, 68, 623-630.
11. Qing-Feng, Z.; Zhong-Rong, Z.; Hon-Yeung, C. Antioxidant activity of Rhizoma smilacis Glabrae extracts and its key constituent-astilbin. Food Chem. 2009, 115, 297-303.
12. Sautour, M.; Miyamoto, T.; Lacaille-Dubois, M.A. Bioactive Steroidal Saponins from Smilax medica. Planta Med. 2006, 72, 667-670.
13. Argueta, A.; Gallardo-Vazquez, M.C. Smilax/Atlas de las Plantas de la Medicina Tradicional Mexicana/Biblioteca Digital de la Medicina Tradicional Mexicana (in Spanish). Available online: http://www.medicinatradicionalmexicana. unam.mx/ (accessed on 3 August 2013).
14. DellaGreca, M.; Cutillo, F.; D'Abrosca, B.; Fiorentino, A.; Pacifico, S.; Zarrelli, A. Antioxidant and radical scavenging properties of Malva sylvestris. Nat. Prod. Commun. 2009, 4, 893-896.
15. Fan, P.; Terrier, L.; Hay, A.E.; Marston, A.; Hostettmann, K. Antioxidant and enzyme inhibition activities and chemical profiles of Polygonum sachalinensis F. Schmidt ex Maxim (Polygonaceae). Fitoterapia 2010, 81, 124-131.
16. Liu, X.; Luo, J.; Kong, L. Phenylethyl cinnamides as potential alpha-glucosidase inhibitors from the roots of Solanum melongena. Nat. Prod. Commun. 2011, 6, 851-853.
17. Yusuf, I.; Yamaoka, K.; Otsuka, H.; Yamasaki, K.; Seyama, I. Block of sodium channels by tyramine and its analogue (N-feruloyl tyramine) in frog ventricular myocytes. Jpn. J. Physiol. 1992, 42, 179-191.
18. Faraci, F.M. Protecting against vascular disease in brain. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, H1566-H1582.
19. Kovacic, J.C.; Moreno, P.; Nabel, E.G.; Hachinski, V.; Fuster, V. Cellular senescence, vascular disease, and aging: Clinical vascular disease in the elderly. Circulation 2011, 123, 1900-1910.
20. Najjar, S.S.; Scuteri, A.; Lakatta, E.G. Arterial aging: Is it an immutable cardiovascular risk factor? Hypertension 2005, 46, 454-462.
21. Yiannikouris, F.; Gupte, M.; Putnam, K.; Thatcher, S.; Charnigo, R.; Rateri, D.L.; Daugherty, A.; Cassis, L.A. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 2012, 60, 1524-1530.
22. Putnam, K.; Shoemaker, R.; Yiannikouris, F.; Cassis, L.A. The renin-angiotensin system: A target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. Am. J. Physiol. Heart Circ. Physiol. 2012, 302, H1219-H1230.
23. Wright, J.W.; Mizutani, S.; Harding, J.W. Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies. Heart Fail. Rev. 2008, 13, 367-375.
24. Ranilla, L.G.; Kwon, Y.I.; Apostolidis, E.; Shetty, K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour. Technol. 2010, 101, 4676-4689.
25. Abdala, S.; Martín-Herrera, D.; Benjumea, D.; Gutiérrez, S.D. Diuretic activity of some Smilax canariensis fractions. J. Ethnopharmacol. 2012, 140, 277-281.
26. Amira, S.; Dade, M.; Schinella, G.; Ríos, J.L. Anti-inflammatory, anti-oxidant, and apoptotic activities of four plant species used in folk medicine in the Mediterranean basin. Pak. J. Pharm. Sci. 2012, 25, 65-72.
27. Khan, I.; Nisar, M.; Ebad, F.; Nadeem, S.; Saeed, M.; Khan, H.; Samiullah, K.; Khuda, F.; Karim, N.; Ahmad, Z. Anti-inflammatory activities of Sieboldogenin from Smilax china Linn.: Experimental and computational studies. J. Ethnopharmacol. 2009, 121, 175-177.
28. Zhang, L.; Liao, C.C.; Huang, H.C.; Shen, Y.C.; Yang, L.M.; Kuo, Y.H. Antioxidant phenylpropanoid glycosides from Smilax bracteata. Phytochemistry 2008, 69, 1398-1404.
29. Fukunaga, T.; Miura, T.; Furuta, K.; Kato, A. Hypoglycemic effect of the rhizomes of Smilax glabra in normal and diabetic mice. Biol. Pharm. Bull. 1997, 20, 44-46.
30. Kim, J.Y.; Park, S.J.; Yun, K.J.; Cho, Y.W.; Park, H.J.; Lee, K.T. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. Eur. J. Pharmacol. 2008, 584, 175-184.
31. Kim, Y.J.; Cho, S.Y.; Yun, C.H.; Moon, Y.S.; Lee, T.R.; Kim, S.H. Transcriptional activation of Cidec by PPARgamma2 in adipocyte. Biochem. Biophys. Res. Commun. 2008, 377, 297-302.
32. Reaven, G.M. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med. 2005, 47, 201-210.
33. Hoffmann, B.R.; El-Mansy, M.F.; Sem, D.S.; Greene, A.S. Chemical proteomics-based analysis of off-target binding profiles for rosiglitazone and pioglitazone: Clues for assessing potential for cardiotoxicity. J. Med. Chem. 2012, 55, 8260-8271.
34. Fonseca, H.A.; Fonseca, F.A.; Monteiro, A.M.; Bianco, H.T.; Boschcov, P.; Brandão, S.A.; Jualiano, L.; Gidlund, M.; Izar, M.C. Obesity modulates the immune response to Oxidized LDL in hypertensive Patients. Cell Biochem. Biophys. 2013, 67, 1451-1460.
35. Zubcevic, J.; Waki, H.; Raizada, M.K.; Paton, J.F. Autonomic-immune- vascular interaciton: An emerging concept for neurogenic hypertension. Hypertension 2011, 57, 1026-1033.
36. Elmarakby, A.A.; Quigley, J.E.; Pollock, D.M.; Imig, J.D. Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 2006, 47, 557-562.
37. Guzik, T.J.; Hoch, N.E.; Brown, K.A.; McCann, L.A.; Rahman, A.; Dikalov, S.; Goronzy, J.; Weyand, C.; Harrison, D.G. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 2007, 204, 2449-2460.
38. Rahman, A.U.; Bhatti, M.K.; Akhtar, F.; Choudhary, M.I. Alkaloids of Fumaria Indica. Phytochemistry 1992, 31, 2869-2872.
39. Empower 2 Guía para el administrador del sistema (In Spanish), 715081098ES; Waters Corporation: Boston, MA, USA, 2008. Available online: http://www.waters.com/webassets/cms/support/docs/wat053020tpr1.pdf (accessed on 3 July 2014).
40. Stat Fax® 2100. Operator's Manual, Revised 01/05. Doc 2100 Rev J; Awareness Technology Inc: Palm City, FL, USA, 1988. Available online: https://extranet.fisher.co.uk/webfiles/fr/Pjointes/Mdemploi/AWA002- EN%20Operating%20manual%202100.pdf (accessed on 2 July 2014).
41. AcqKnowledge 4 Software Guide. Data Acquisition and Analysis with BIOPAC Hardware System. BIOPAC Systems Inc: Goleta, CA, USA, 2012. Available online: http://www.biopac.com/Manuals/acqknowledge%204%20software%20guide.pdf (accessed on 2 July 2014).